Skip to content
MarketScale
‹ Back to IndustriesHealthcare

TECHNOLOGY READINESS ASSESSMENTS AND MITIGATIONS

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development. Integrating technology readiness reviews into the product…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

New product development efforts are a significant investment. Whether it is an established company that is acquiring new technology, or a startup with a new product concept hoping to move to commercialization; decisions should be made regarding what needs to be de-risked before moving to formal product development.

Integrating technology readiness reviews into the product development process enables actionable processes that reduce project risk. This helps to avoid project delays, potential budgetary concerns, or the pressure to make design/feature compromises.

To determine whether a potential product has adequate technical maturity to effectively launch formal product development, the following steps should be considered:

  • Determine the stage of maturity of the current technology
  • Understand the implications of technology and project risks
  • Model, take measurements and analyze to decide whether core technology is capable of meeting the product requirements
  • Demonstrate that the device can provide adequate performance over the expected range of conditions
  • Determine whether the technology can scale to volume manufacturing and distribution

Evaluations begin with an objective review of each core technology critical to the operability of the device that may delay or prohibit market introduction.

This may involve proving whether core technology is adequate for use in a particular application. For example, does the new sensor being developed operate over the variety of conditions needed? Will environmental effects cause problems? Are measurements and control mechanisms adequate to provide safe and effective outcomes? Are there manufacturing difficulties in achieving the needed tolerances? These and other questions are explored, and appropriate efforts made, to bring the technology readiness level to the point that justifies moving the project to its subsequent phases.

Technology Readiness Assessment Tailored to Medical Devices

At Sunrise Labs, we implement a rigorous Technology Readiness Assessment customized specifically for medical devices. By analyzing the maturity of the technologies and the risk that each stage incurs, our assessment determines what challenges must be overcome in order for a device to be successfully engineered and commercialized.

We then improve the Technology Readiness through our feasibility Phase 0 process to prepare for a successful development effort.

To learn more about our process, check out our video on Technology Readiness.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient AI is moving from clinician productivity to consent and revenue-cycle controls

Ambient artificial intelligence (AI) in healthcare is rapidly advancing from enhancing clinician productivity to broader applications in consent and revenue-cycle control. Hospitals must now manage the use of ambient documentation tools, such as microphones and AI models, with the same scrutiny as other operational technologies. This evolution underscores the growing importance of governing AI technologies in clinical settings to ensure compliance and effectiveness.

  • 01Hospitals are increasingly using ambient AI for tasks beyond clinician productivity, including managing consent and revenue cycles.
  • 02The deployment of ambient documentation requires hospitals to regulate microphones and AI models as strictly as other technologies.
  • 03The expansion of ambient AI in healthcare signifies a shift towards comprehensive governance of AI tools.

Aug 20, 2026

Connected Across Texas - Leah Barton

The article discusses healthcare connectivity efforts in Texas, focusing on Healthconnect TX's role. Connectivity is emphasized as crucial for efficient healthcare service delivery in the region.

  • 01Healthcare connectivity is vital for efficient service delivery.
  • 02Healthconnect TX is working to enhance healthcare connectivity in Texas.

Aug 18, 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Investment in health tech AI is increasing, with significant funding directed towards chronic care, home health, and workforce training. In June, there were four major funding rounds totaling $335 million aimed at improving these areas. The focus includes AI scheduling and home care operations.

  • 01Four major health tech funding rounds totaling $335 million were closed in June.
  • 02Investments are targeting chronic disease management, AI scheduling, and home care operations.
  • 03Workforce training in the healthcare sector is a key area receiving funding.

Aug 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512